U.S. Radiation Oncology Market Size & Outlook, 2026-2033

Name: U.S. Radiation Oncology Market Size & Outlook
Creator: Grand View Research
License: https://www.grandviewresearch.com/horizon/info/terms-of-use

The radiation oncology market in the United States is expected to reach a projected revenue of US$ 13,677.0 million by 2033. A compound annual growth rate of 11.4% is expected of the United States radiation oncology market from 2026 to 2033.

U.S. radiation oncology treatment type outlook (Revenue, USD million, 2021-2033)
- External Beam Radiation Therapy (EBRT)
  - Linear Accelerators (LINAC)
  - Stereotactic Radiosurgery (SRS) Systems
  - Tomotherapy Systems
  - Particle Beam Therapy
- Internal Beam Radiation Therapy
  - Brachytherapy
    - Low-Dose Rate (LDR) Brachytherapy
      - Seeds
    - High-Dose Rate (HDR) Brachytherapy
      - Afterloaders
      - Applicators
    - Electronic Brachytherapy
- Systemic Targeted Radiation Therapy
  - Radioligand Therapy (RLT)
    - Beta-Emitting Radioligand Therapies
    - Alpha-Emitting Radioligand Therapies
U.S. radiation oncology technology outlook (Revenue, USD million, 2021-2033)
- Image-Guided Radiotherapy (IGRT)
  - Motion Tracking / Real-Time Tumor Tracking
  - Other
- Intensity-Modulated Radiotherapy (IMRT)
- Volumetric Modulated Arc Therapy (VMAT)
- 3D Conformal Radiation Therapy (3D-CRT)
- Stereotactic Radiotherapy (SRS / SBRT)
- Proton Beam Delivery Technology
- Heavy-Ion Delivery Technology
- Adaptive Radiotherapy
- Upright Beam Delivery Technology
U.S. radiation oncology application outlook (Revenue, USD million, 2021-2033)
- External Beam Radiation Therapy (EBRT)
  - Prostate Cancer
  - Breast Cancer
  - Lung Cancer
  - Head & Neck Cancer
  - Colorectal Cancer
  - Central Nervous System (CNS) Tumors
  - Others (e.g., Pediatric Cancers)
- Internal Beam Radiation Therapy
  - Prostate Cancer
  - Gynecological Cancer
  - Cervical Cancer
  - Breast Cancer
  - Others (e.g., Penile Cancer)
- Radioligand Therapy Applications
  - Prostate Cancer
  - Neuroendocrine Tumors
  - Thyroid Cancer
  - Others (e.g., Hematologic Malignancies)
U.S. radiation oncology target customer outlook (Revenue, USD million, 2021-2033)
- Academic & Research Cancer Centers
- Government & Public Tertiary Hospitals
- Private Oncology Chains
- Specialty Proton / Particle Therapy Centers
- Nuclear Medicine & Theranostics Centers

U.S. Radiation Oncology Market Size & Outlook, 2026-2033

Sign up - it's easy, and free!